国药控股涨超3% 本周将发三季度业绩 国药股份第三季纯利同比增长13.1%

Group 1 - The core point of the article is that China National Pharmaceutical Group (国药控股) shares have increased by over 3%, currently trading at HKD 19.33 with a transaction volume of HKD 71.91 million [1] - The company will hold a board meeting on October 24 to consider and approve the unaudited quarterly results for the nine months ending September 30, 2025 [1] - China National Pharmaceutical's subsidiary, China National Pharmaceutical Co., reported a third-quarter revenue of RMB 13.747 billion, representing a year-on-year growth of 3.58% [1] Group 2 - The net profit attributable to shareholders for the subsidiary in the third quarter was RMB 544 million, showing a year-on-year increase of 13.10% [1]